(0.04%) 5 471.40 points
(0.08%) 39 145 points
(0.36%) 17 781 points
(-0.01%) $80.82
(-3.66%) $2.66
(-0.80%) $2 312.20
(0.18%) $28.92
(3.49%) $1 020.80
(0.27%) $0.936
(0.67%) $10.67
(0.42%) $0.792
(-0.27%) $87.25
8.48% $ 0.385
Live Chart Being Loaded With Signals
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells...
Stats | |
---|---|
Volumen de hoy | 94 426 |
Volumen promedio | 262 332 |
Capitalización de mercado | 9.57M |
EPS | $-0.240 ( Q2 | 2023-08-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.225 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0390 (10.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-08-23 | Zabrowksi Dan | Sell | 100 000 | Stock Option (right to buy) |
2023-08-23 | Wertheimer Samuel P | Sell | 146 383 | Common Stock |
2023-08-23 | Wertheimer Samuel P | Sell | 100 000 | Stock Option (right to buy) |
2023-08-23 | Wertheimer Samuel P | Sell | 12 383 | Warrants (right to buy) |
2023-08-23 | Wertheimer Samuel P | Sell | 1 845 | Warrants (right to buy) |
INSIDER POWER |
---|
-63.03 |
Last 97 transactions |
Buy: 2 466 920 | Sell: 6 182 886 |
Volumen Correlación
Apexigen, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Apexigen, Inc. Correlación - Moneda/Commodity
Apexigen, Inc. Finanzas
Annual | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-1.590 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-1.590 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.931 |
FY | 2020 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-3.36 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Apexigen, Inc.
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico